Browsing Tag
NASDAQ
289 posts
NVIDIA company profile: Business model, financials, and growth outlook (2025 edition)
Discover the full NVIDIA company profile—business model, financials, stock outlook, and growth drivers for 2025. Read the full analysis now.
ZoomInfo stock soars 10% as AI-driven ‘go-to-market studio’ unleashes new growth hopes
ZoomInfo stock jumped 10% after Q1 earnings, AI launch, and a ticker change to ‘GTM.’ Find out what’s driving investor optimism and what’s next.
Bitdeer Technologies explodes 10% as bitcoin nears $69K—Is the crypto mining boom back?
Bitdeer stock surged as Bitcoin retested $69K. Explore what’s driving BTDR’s rise, Q1 earnings, analyst calls, and crypto ETF momentum.
Regencell Bioscience surges 9.86% amid low-float frenzy, but fundamentals remain
Regencell Bioscience (RGC) jumps 9.86% to $342.99 on low volume. Find out what’s driving the surge—and why institutions are still staying away.
DeFi Technologies secures Nasdaq listing as Valour expands ETP ecosystem across Europe
DeFi Technologies gains Nasdaq listing approval as Valour expands digital asset ETPs in Europe—find out what this means for investors and the future of DeFi.
Microchip Technology stock rallies 12.6% after Q4 FY25 results hint at semiconductor downturn bottom
Microchip shares surged 12.6% as Q4 FY25 results suggest industry bottom. Learn how MCHP is realigning for AI, EV, and industrial recovery.
Xiao-I and AIA China deepen AI partnership to transform customer engagement in insurance sector
Xiao-I expands AI services for AIA China in a RMB 3–4M deal, deploying Hua Zang LLM to automate customer engagement as stock eyes modest rebound.
Equifax and Galaxy skyrocket as Wall Street recovers 1,000+ points in a day
U.S. stocks surged April 22 as Equifax, First Solar, and Galaxy Digital led gains on earnings strength and trade optimism. See top stock market trends today.
Brain cancer breakthrough? Telix Pharmaceuticals’ TLX101 boosts survival in early study as stock outlook strengthens
Discover how Telix’s TLX101 therapy is showing new promise for brain cancer as investor sentiment rises with key study results and clinical trial expansion.
Markets crash after Trump’s “beautiful” tariffs go live—what comes next?
Find out why President Trump’s sweeping tariffs are shaking global markets and what this means for the future of U.S. trade and the world economy.